Back to News
Market Impact: 0.05
Avicanna to Present at the Life Sciences Investor Forum on Sep 17th
Source: GlobeNewswire
Healthcare & Biotech
The company invited life-sciences investors, advisors and analysts to attend live interactive presentations through VirtualInvestorConferences.com. The announcement provides no financial results, operating updates, guidance, or other material corporate developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Anthropic's IPO push includes a big bet on life sciences
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Illumina CEO on Q3 Results and Business Outlook
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand